查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1458417

全球神經修復市場：依產品、應用、最終用戶和地區劃分的機會和預測（2017-2031）

Nerve Repair Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 233 Pages | 商品交期: 3-5個工作天內

價格

全球神經修復市場規模預計將從2023年的81.2億美元成長到2031年的197.7億美元，在2024-2031年的預測期內複合年增長率為11.77%。支持該市場成長的各種因素包括老年人口的增加、研究活動的增加、與神經損傷相關的病例數量的增加以及策略聯盟和收購。

帕金森氏症和阿茲海默症等各種慢性神經系統疾病的盛行率不斷增加，增加了對神經修復解決方案的需求。加大努力確保提供增強的治療解決方案加上技術進步正在支持神經修復市場的成長。不斷增加的研究活動正在幫助研究人員找到治療和診斷多種神經系統疾病的先進和新穎的解決方案。這些活動還提供了對疾病和病症的深入瞭解，並支持臨床治療實踐。各公司增加的研究合作和收購正在將創新產品和技術推向更廣泛的市場，並為醫生提供廣泛的基於證據的治療方案，以解決多個疼痛目標。

該報告研究了全球神經修復市場，並提供了市場概述，包括依產品、應用、最終用戶、地區和參與市場的公司概況劃分的趨勢。

目錄

第一章研究方法論

第二章 專案範圍與定義

第三章執行摘要

第四章 2017-2031 年全球神經修復市場展望

  • 市場規模及預測
  • 依產品
  • 依用途
  • 依最終用戶
  • 依地區
  • 依公司劃分的市佔率 (%)，2023 年

第五章 2017-2031 年全球神經修復市場展望（依地區）

  • 北美
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東/非洲

第六章 2023 年市場規劃

第七章 宏觀環境與產業結構

  • 供需分析
  • 進出口分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第八章市場動態

第九章 監理架構與創新

第十章 主要與企業狀況

第11章價格分析

第十二章案例研究

第十三章 主要進入者展望

  • AxoGen, Inc.
  • Abbott Laboratories
  • Baxter International, Inc.
  • Integra Lifesciences Corporation
  • Boston Scientific, Inc.
  • Medtronic Plc
  • Stryker Corporation
  • Cyberonics, Inc.
  • Polyganics B.V.
  • OrthoMed, Inc.

第十四章 戰略建議

第十五章 查詢及免責聲明

Product Code: MX11214

The global nerve repair market is projected to witness a CAGR of 11.77% during the forecast period 2024-2031F, growing from USD 8.12 billion in 2023 to USD 19.77 billion in 2031F. The different factors supporting the growth of the market include the increasing geriatric population, rising research activities, growing incidences related to nerve injuries, and strategic collaborations and acquisitions.

The growing prevalence of various chronic neurological conditions, such as Parkinsons' and Alzheimer's disease, is bolstering the requirement for nerve repair solutions. Increasing efforts towards ensuring the provision of enhanced treatment solutions, coupled with technological advancements, are supporting the nerve repair market growth. Rising research activities are aiding researchers in identifying advanced and novel solutions for treating and diagnosing several neurological diseases. These activities also provide insights into diseases and disorders and support the clinical practice of the treatment. The growing collaborations and acquisitions by various companies are ensuring that the innovative products and technologies have a broad market outreach and physicians are provided with a range of evidence-based treatment options that address multiple pain targets.

The increased provision of clearance by the Food and Drug Administration (FDA) to different devices for both home and clinical use is further providing lucrative growth opportunities to the market. For instance, in 2022, MyndTec received 510(k) clearance for MyndMove 2.0, their second-generation neuromodulation MyndMove System. The MyndMove System is an eight-channel neuromodulation device that allows the delivery of short electrical pulses for stimulating enhanced motor recovery and muscle contraction, following a spinal cord injury or stroke. The system includes hand and foot switches, electrodes, stimulator unit, and integrated software, allowing users to choose from different pre-programmed stimulation protocols for customizing the stimulation intensities for different patients.

Increasing Introduction of Novel Products Support Nerve Repair Market Growth

The rising introduction of novel products can be attributed to the increased research and development activities. The various research activities are focused on enhancing neuromodulation and neurostimulation technologies, along with the development of next-generation neuromodulation devices. Various companies are also investing in launching new medical devices. For instance, in 2023, Axogen, a Tempa-based developer of different surgical solutions, including human tissue grafts, launched nerve repair products for cancer and trauma patients. The company is commercializing and testing products to address two major requirements of the healthcare sector: peripheral nerve repair and regeneration. Over the past several years, the company has introduced various novel nerve repair applications that are utilized in Axoguard and Avance product lines. The patients who were scheduled for the procedure were seeking relief from a condition that was caused by a surgical procedure or a nerve defect. This included nerve reconstruction following the removal of neuromas, nerve decompression, breast reconstruction post-mastectomy, and oral and maxillofacial procedures.

Growing Prevalence of Neurological Disorders

The increasing prevalence of different neurological disorders is one of the major factors supporting the market expansion and bolstering the global nerve repair market demand. According to the World Health Organization (WHO), neurological disorders are the second leading cause of death across the globe, accounting for approximately 9 million deaths every year, and are the leading cause of disability-adjusted life years. The increase in the number of neurological disorders can be attributed to the growth of the geriatric population. Due to aging, the number of patients with neurodegenerative diseases and neurological problems is increasing. The rise in the number of vehicular accidents is another major factor boosting the number of nerve injuries. The increasing prevalence of different neurological disorders, such as Alzheimer's and Parkinson's disease, can also be attributed to the growing exposure to environmental toxins, which, in turn, is one of the factors responsible for the global nerve repair market expansion.

North America Accounts for a Significant Share of the Market

North America holds a significant nerve repair market share in the global landscape due to the availability of technologically advanced solutions and devices, presence of a well-established healthcare infrastructure, and the increasing prevalence of neural disorders. The strong presence of various market players and increasing research and development activities are supporting novel product development, thereby accelerating the region's expansion in the market. Strategic mergers and acquisitions in the region are further expected to offer lucrative growth opportunities to the market. For instance, Boston Scientific, headquartered in Massachusetts, United States, known for providing innovative medical solutions, acquired Relievant Medsystems, the company known for offering Food and Drug Administration-cleared Intracept Intraosseous Nerve Ablation System. The basivertebral nerve ablation therapy is expected to enhance Boston Scientific's chronic pain portfolio which includes interspinous spacer procedure, radiofrequency ablation, and spinal cord stimulation. The completion of the acquisition is expected to offer physicians a wide range of evidence-based treatment options for addressing multiple pain targets.

Neuromodulation Devices Account for Significant Global Nerve Repair Market Share

The neuromodulation devices are anticipated to account for a significant share of the market over the forecast period. This growth can be attributed to the technological advancements in device development and rising awareness among end users. The increasing provision of funding by various governments for supporting different R&D activities is further boosting segment expansion. Additionally, the Food and Drug Administration (FDA) is also approving neuromodulation devices. For instance, in 2023, the FDA approved a bimodal neuromodulation device, the first of its kind for treating tinnitus. The device provides electrical stimulation to the tongue and non-invasive sound for alleviating symptoms of chronic tinnitus. The decision was based on the findings of the TENT-A3 trial. The single-arm prospective study aimed to determine if tongue stimulations offered additional benefits as opposed to sound-only treatment. The study compared the effects of six weeks of sound therapy alone versus six weeks of bimodal neuromodulation from March to October 2022.

Stem Cell Therapy Witness Significant Growth

The expansion of the segment can be attributed to the rising demand for effective treatment solutions, increasing research and development activities, the growing prevalence of neurological conditions, and supportive government initiatives. The rising research and development activities are aiding researchers in developing novel treatment solutions for repairing nerves. For instance, a team of researchers from the University of Pennsylvania School of Dental Medicine and Perelman School of Medicine created a new approach that relies upon the versatility of gingiva-derived mesenchymal stem cells for surgically repairing injured peripheral nerves. This new approach marries the biological scaffold with the power of regeneration of gingiva-derived mesenchymal stem cells, enabling the functional recovery of nerves. The Penn team was able to grow Schwann-like cells from the human gingiva-derived mesenchymal stem cells (GMSCs). The Schwann-like cells are the pro-regenerative cells of the peripheral nervous system that are responsible for making neural growth factors and myelin.

Future Market Scenario (2024 - 2031F)

Different research and development activities are being conducted to assess the safety and efficacy of different treatment solutions available for nerve repair. For instance, the University of Miami is conducting an interventional study to assess the safety of the autologous human Schwann cell augmentation in participants with severe peripheral nerve injury for nerve autograft repair. For individuals with acute severe peripheral nerve injury, it is hypothesized that the augmentation of nerve autograft repair with autologous human Schwann cells can potentially enhance myelin repair and axonal regeneration, improving functional recovery. The study is expected to conclude in September 2025. Different emerging technologies are paving the way for the next generation of medical devices that can be deployed by surgeons during surgeries for healing nerves, along with other tissues shortly. These devices are expected to offer various benefits such as deployment by minimally invasive procedures, reduced complexity of surgeries, and faster healing.

Key Players Landscape and Outlook

Key participants in the global repair market are AxoGen, Inc., Abbott Laboratories, Baxter International, Inc., Boston Scientific, Inc., and Medtronic Plc. The market expansion is supported by the increasing prevalence of neural disorders and strategic partnerships between various companies.

For instance, in 2023, MyndTec Inc. and Fourier Intelligence announced a strategic partnership to support the distribution of MyndMoveTM a functional electrical stimulation-based non-invasive intervention. The global network of Fourier spans over fifty countries, ensuring a wide market outreach for innovative products and technologies. MyndMoveTM therapy is supported by different clinical studies such as randomized controlled trials in spinal cord injuries and strokes. The stimulation protocols in MyndMoveTM allow doctors to stimulate functional, natural, and purposeful movements in patients.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Nerve Repair Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
    • 4.1.2.By Volume
  • 4.2.By Product
    • 4.2.1.Neurostimulation Devices
    • 4.2.2.Biomaterials
    • 4.2.3.Neuromodulation Devices
  • 4.3.By Application
    • 4.3.1.Nerve Grafting
    • 4.3.2.Stem Cell Therapy
    • 4.3.3.Neurostimulation and Neuromodulation Surgeries
    • 4.3.4.Direct Nerve Repair/Neurorrhaphy
    • 4.3.5.Others
  • 4.4.By End-user
    • 4.4.1.Hospitals
    • 4.4.2.Ambulatory Surgical Centers
    • 4.4.3.Specialty Clinics
  • 4.5.By Region
    • 4.5.1.North America
    • 4.5.2.South America
    • 4.5.3.Europe
    • 4.5.4.Asia-Pacific
    • 4.5.5.Middle East & Africa
  • 4.6.By Company Market Share (%), 2023

5.Global Nerve Repair Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Product
      • 5.1.2.1.Neurostimulation Devices
      • 5.1.2.2.Biomaterials
      • 5.1.2.3.Neuromodulation Devices
    • 5.1.3.By Application
      • 5.1.3.1.Nerve Grafting
      • 5.1.3.2.Stem Cell Therapy
      • 5.1.3.3.Neurostimulation and Neuromodulation Surgeries
      • 5.1.3.4.Direct Nerve Repair/Neurorrhaphy
      • 5.1.3.5.Others
    • 5.1.4.By End-user
      • 5.1.4.1.Hospitals
      • 5.1.4.2.Ambulatory Surgical Centers
      • 5.1.4.3.Specialty Clinics
    • 5.1.5.United States*
      • 5.1.5.1.Market Size & Forecast
      • 5.1.5.1.1.By Value
      • 5.1.5.1.2.By Volume
      • 5.1.5.2.By Product
      • 5.1.5.2.1.Neurostimulation Devices
      • 5.1.5.2.2.Biomaterials
      • 5.1.5.2.3.Neuromodulation Devices
      • 5.1.5.3.By Application
      • 5.1.5.3.1.Nerve Grafting
      • 5.1.5.3.2.Stem Cell Therapy
      • 5.1.5.3.3.Neurostimulation and Neuromodulation Surgeries
      • 5.1.5.3.4.Direct Nerve Repair/Neurorrhaphy
      • 5.1.5.3.5.Others
      • 5.1.5.4.By End-user
      • 5.1.5.4.1.Hospitals
      • 5.1.5.4.2.Ambulatory Surgical Centers
      • 5.1.5.4.3.Specialty Clinics
    • 5.1.6.Canada
    • 5.1.7.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East & Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Product
  • 6.2.By Application
  • 6.3.By End-user
  • 6.4.By Region

7.Macro Environment and Industry Structure

  • 7.1.Supply Demand Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat from New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Patent Landscape
  • 9.2.Regulatory Approvals
  • 9.3.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.AxoGen, Inc.
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products & Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus & Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Abbott Laboratories
  • 13.3.Baxter International, Inc.
  • 13.4.Integra Lifesciences Corporation
  • 13.5.Boston Scientific, Inc.
  • 13.6.Medtronic Plc
  • 13.7.Stryker Corporation
  • 13.8.Cyberonics, Inc.
  • 13.9.Polyganics B.V.
  • 13.10.OrthoMed, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14.Strategic Recommendations

15.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 2.Global Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 3.Global Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 4.Global Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 5.Global Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 6.Global Nerve Repair Market Share (%), By Region, 2017-2031F
  • Figure 7.North America Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 8.North America Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 9.North America Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 10.North America Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 11.North America Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 12.North America Nerve Repair Market Share (%), By Country, 2017-2031F
  • Figure 13.United States Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 14.United States Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 15.United States Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 16.United States Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 17.United States Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 18.Canada Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 19.Canada Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 20.Canada Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 21.Canada Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 22.Canada Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 23.Mexico Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 24.Mexico Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 25.Mexico Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 26.Mexico Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 27.Mexico Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 28.Europe Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 29.Europe Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 30.Europe Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 31.Europe Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 32.Europe Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Nerve Repair Market Share (%), By Country, 2017-2031F
  • Figure 34.Germany Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 35.Germany Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 36.Germany Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 37.Germany Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 38.Germany Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 39.France Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 40.France Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 41.France Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 42.France Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 43.France Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 44.Italy Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 45.Italy Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 46.Italy Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 47.Italy Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 48.Italy Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 49.United Kingdom Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 50.United Kingdom Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 51.United Kingdom Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 52.United Kingdom Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 53.United Kingdom Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 54.Russia Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 55.Russia Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 56.Russia Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 57.Russia Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 58.Russia Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 59.Netherlands Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 60.Netherlands Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 61.Netherlands Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 62.Netherlands Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 63.Netherlands Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 64.Spain Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 65.Spain Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 66.Spain Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 67.Spain Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 68.Spain Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 69.Turkey Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 70.Turkey Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 71.Turkey Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 72.Turkey Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 73.Turkey Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 74.Poland Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 75.Poland Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 76.Poland Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 77.Poland Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 78.Poland Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 79.South America Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 80.South America Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 81.South America Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 82.South America Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 83.South America Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 84.South America Nerve Repair Market Share (%), By Country, 2017-2031F
  • Figure 85.Brazil Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 86.Brazil Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 87.Brazil Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 88.Brazil Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 89.Brazil Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 90.Argentina Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 91.Argentina Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 92.Argentina Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 93.Argentina Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 94.Argentina Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 95.Asia-Pacific Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 96.Asia-Pacific Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 97.Asia-Pacific Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 98.Asia-Pacific Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 99.Asia-Pacific Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 100.Asia-Pacific Nerve Repair Market Share (%), By Country, 2017-2031F
  • Figure 101.India Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 102.India Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 103.India Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 104.India Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 105.India Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 106.China Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 107.China Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 108.China Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 109.China Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 110.China Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 111.Japan Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 112.Japan Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 113.Japan Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 114.Japan Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 115.Japan Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 116.Australia Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 117.Australia Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 118.Australia Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 119.Australia Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 120.Australia Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 121.Vietnam Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 122.Vietnam Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 123.Vietnam Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 124.Vietnam Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 125.Vietnam Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 126.South Korea Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 127.South Korea Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 128.South Korea Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 129.South Korea Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 130.South Korea Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 131.Indonesia Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 132.Indonesia Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 133.Indonesia Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 134.Indonesia Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 135.Indonesia Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 136.Philippines Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 137.Philippines Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 138.Philippines Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 139.Philippines Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 140.Philippines Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 141.Middle East & Africa Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 142.Middle East & Africa Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 143.Middle East & Africa Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 144.Middle East & Africa Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 145.Middle East & Africa Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 146.Middle East & Africa Nerve Repair Market Share (%), By Country, 2017-2031F
  • Figure 147.Saudi Arabia Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 148.Saudi Arabia Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 149.Saudi Arabia Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 150.Saudi Arabia Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 151.Saudi Arabia Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 152.UAE Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 153.UAE Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 154.UAE Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 155.UAE Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 156.UAE Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 157.South Africa Nerve Repair Market, By Value, in USD Billion, 2017-2031F
  • Figure 158.South Africa Nerve Repair Market, By Volume, in Million Units, 2017-2031F
  • Figure 159.South Africa Nerve Repair Market Share (%), By Product, 2017-2031F
  • Figure 160.South Africa Nerve Repair Market Share (%), By Application, 2017-2031F
  • Figure 161.South Africa Nerve Repair Market Share (%), By End-user, 2017-2031F
  • Figure 162.By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163.By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023